Tomarket Launches Telegram Ecosystem FarmingPool Product, Supports Users to Earn Points and Token Airdrops
On October 30th, Tomarket, a Telegram & TON eco-app, announced the launch of the first FarmingPool product in the Telegram eco-system, which provides users with an aggregated coin-earning platform. In the future, users can earn points or token airdrops for high-quality projects by pledging Tomarket's official token, TOMA, or by completing tasks such as friend invitations.
As previously reported, Tomarket plans to conduct a TGE for the token TOMA on October 31 at 23:59 As a new Web3 asset platform invested by Bitget Wallet and Foresight X, Tomarket is committed to attracting more Web2 users to learn about and enter the Web3 world through products and services such as Game, Earn, and Trade, and its user base has exceeded 43 million in the past four months since it was launched, and its on-chain users have exceeded 10 million, making it one of the top 3 Telegram Mini-Mini-Markets. Since its launch four months ago, the number of users has exceeded 43 million, and the number of on-chain users has exceeded 10 million, making it one of the top 3 Telegram Mini-Apps.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.
U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).
Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential
According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.
Autoimmune and inflammatory disease pharmaceutical company TRex Bio (TRX.US) applies for US listing, plans to raise up to 100 millions dollars.
TRex Bio filed documents with the U.S. Securities and Exchange Commission (SEC) last Friday, intending to raise up to 100 million USD through an initial public offering (IPO).
Crypto prices
More
